Recombinant Shigella sonnei Protein psiE (psiE)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Shigella sonnei Protein psiE (psiE)

Recombinant Shigella sonnei Protein psiE (psiE) is a protein derived from the bacterium Shigella sonnei, a leading cause of shigellosis, particularly in industrialized countries. Shigella sonnei is a Gram-negative, non-spore-forming, nonmotile, facultative aerobic bacterium closely related to Escherichia coli (E. coli) . The psiE protein is specifically expressed in Shigella sonnei and has been studied for its potential applications in research and vaccine development.

Characteristics of Recombinant Shigella sonnei Protein psiE (psiE)

  • Source and Expression: The recombinant psiE protein is typically expressed in E. coli, yeast, baculovirus, or mammalian cells . This versatility in expression systems allows for the optimization of protein production based on specific requirements.

  • Sequence and Structure: The psiE protein consists of 136 amino acids, with a specific sequence that defines its structure and function . The amino acid sequence is crucial for understanding its role in Shigella sonnei and potential interactions with host cells.

  • Storage and Handling: The recombinant protein is usually stored in a Tris-based buffer with 50% glycerol at -20°C to maintain stability. Repeated freezing and thawing should be avoided to preserve protein integrity .

Table 1: Characteristics of Recombinant Shigella sonnei Protein psiE (psiE)

CharacteristicDescription
SourceE. coli, Yeast, Baculovirus, Mammalian Cells
Sequence Length136 Amino Acids
Storage Conditions-20°C, Tris-based buffer with 50% glycerol
Expression SystemVarious (e.g., E. coli)

Table 2: Potential Applications of Shigella Proteins

ApplicationDescription
Vaccine DevelopmentExploration of proteins for broad-spectrum vaccines against Shigella
Diagnostic ToolsPotential use in developing diagnostic assays for Shigella infections
ResearchStudy of protein structure, function, and interactions with host cells

References e-scapebio. ELISA Recombinant Shigella sonnei Protein psiE (psiE). Frontiers in Cellular and Infection Microbiology. Shigella Diversity and Changing Landscape: Insights for the Twenty-First Century. Creative Biolabs. Recombinant Shigella Sonnei psiE Protein (aa 1-136). Hanyang University Repository. Shigella Outer Membrane Protein PSSP-1 Is Broadly Protective. PMC. Outer membrane proteins analysis of Shigella sonnei. PMC. Shigella virulence protein VirG is a broadly protective antigen.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format readily available in our inventory, we are receptive to specific format requests. Please indicate your desired format in the order notes, and we will accommodate your needs whenever possible.
Lead Time
Delivery timelines may vary depending on the purchase method and location. For precise delivery estimates, we encourage you to consult your local distributors.
Note: All protein shipments are standardly accompanied by blue ice packs. If dry ice packaging is preferred, please communicate this request in advance, as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. For optimal preservation, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly before opening to ensure the contents settle at the bottom. Reconstitute the protein in deionized sterile water to a concentration ranging from 0.1 to 1.0 mg/mL. For long-term storage, we advise adding 5-50% glycerol (final concentration) and aliquoting the solution, storing it at -20°C/-80°C. Our default final glycerol concentration is 50%, which can serve as a reference for your preparations.
Shelf Life
The shelf life of our products is influenced by various factors, including storage conditions, buffer composition, temperature, and the inherent stability of the protein itself.
Generally, the shelf life of liquid forms is 6 months at -20°C/-80°C. Lyophilized forms typically have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store the protein at -20°C/-80°C. For multiple use, aliquoting is recommended. Minimize repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process.
The tag type is determined during production. If you have a specific tag type requirement, please inform us, and we will prioritize its implementation whenever feasible.
Synonyms
psiE; SSON_4208; Protein PsiE
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-136
Protein Length
full length protein
Species
Shigella sonnei (strain Ss046)
Target Names
psiE
Target Protein Sequence
MTSLSRPRVEFISTILQTVLNLGLLCLGLILVVFLGKETVHLADVLFAPEQTSKYELVEG LVVYFLYFEFIALIVKYFQSGFHFPLRYFVYIGITAIVRLIIVDHKSPLDVLIYSAAILL LVITLWLCNSKRLKRE
Uniprot No.

Target Background

Database Links
Protein Families
PsiE family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

Basic Research Questions

  • What is Shigella sonnei Protein psiE and what is its significance in research?

    Shigella sonnei Protein psiE (psiE) is a bacterial protein expressed by Shigella sonnei, a Gram-negative bacterium responsible for shigellosis, a form of bacillary dysentery. The protein is of significant research interest due to its potential role in Shigella pathogenesis. Research into psiE is particularly important because Shigella has been shown to have a stronger relationship to linear growth faltering (LGF) than many other enteropathogens, with higher bacterial loads resulting in greater growth deficits . Understanding psiE's function may contribute to developing more effective prevention strategies against Shigella infections, which are commonly detected in toddlers and young children but can cause more severe disease in infants .

  • What are the molecular characteristics of psiE protein?

    Recombinant Shigella sonnei Protein psiE is characterized by:

    • Amino Acid Sequence: MTSLSRPRVEFISTILQTVLNLGLLCLGLILVVFLGKETVHLADVLFAPEQTSKYELVEGLIVYFLYFEFIALIVKYFQSGFHFPLRYFVYIGITAIVRLIIVDHKSPLDVLIYSAAILLVITLWLCNSKRLKRE

    • Origin: Derived from Shigella sonnei (strain Ss046)

    • UniProt Accession Number: Q3YUV5

    • Protein Length: 136 amino acids (expression region 1-136)

    • Structural Features: Contains hydrophobic regions suggesting membrane association

    Researchers analyzing the sequence should note the presence of transmembrane domains and potential epitope regions that may be important for immunological studies.

  • What are the recommended storage and handling practices for recombinant psiE?

    For optimal research outcomes, recombinant psiE requires specific storage and handling protocols:

    • Long-term Storage: Store at -20°C or -80°C for extended preservation

    • Working Conditions: Maintain working aliquots at 4°C for up to one week

    • Buffer Composition: Typically stored in Tris-based buffer with 50% glycerol optimized for protein stability

    • Freeze-Thaw Cycles: Repeated freezing and thawing is not recommended as it may lead to protein degradation or loss of activity

    Researchers should validate protein integrity after storage using appropriate analytical methods such as SDS-PAGE or Western blotting before experimental use.

  • What experimental systems are suitable for studying psiE function?

    Several experimental systems can be employed to study psiE function:

    Experimental SystemApplicationAdvantagesLimitations
    In vitro cell cultureHost-pathogen interactionsControlled environment, easier manipulationMay not fully recapitulate in vivo conditions
    BALB/c mice modelsImmunological studiesWell-established immune response modelSpecies differences from human responses
    Bioinformatic analysisStructural predictions, epitope mappingNon-invasive, hypothesis generatingRequires experimental validation
    ELISA-based assaysProtein-protein interactions, antibody bindingQuantitative, high sensitivityLimited to interactions that can be detected by available antibodies

    Animal models, particularly BALB/c mice, have been successfully used for immunization studies against Shigella sonnei using multiepitope protein vaccine constructs .

  • How can researchers verify the identity and purity of recombinant psiE?

    Verification of recombinant psiE identity and purity should involve multiple complementary approaches:

    1. Mass Spectrometry: For accurate molecular weight determination and sequence verification

    2. SDS-PAGE: To assess purity and approximate molecular weight

    3. Western Blotting: Using specific antibodies to confirm protein identity

    4. N-terminal Sequencing: To verify the first 5-10 amino acids match the expected sequence

    5. Functional Assays: To confirm biological activity is consistent with predicted function

    Researchers should establish acceptance criteria for purity (typically >90%) and identity confirmation before proceeding with experimental work.

Advanced Research Questions

  • How can researchers address contradictory findings in psiE research?

    Contradictory findings in psiE research can be methodically addressed through:

    1. Systematic Review Approach: Compile all available data on psiE using standardized inclusion criteria

    2. Statistical Meta-analysis: When sufficient quantitative data is available

    3. Contradiction Detection Methodologies: Apply clinical contradiction detection approaches as demonstrated in medical literature analysis

    4. Context-Dependent Analysis: Examine experimental conditions, strains, and methodologies that might explain divergent results

    5. Replication Studies: Design experiments specifically to test contradictory findings under identical conditions

    Recent advances in clinical contradiction detection using distant supervision approaches and deep learning models can be particularly useful for analyzing conflicting statements in medical literature about psiE function . This approach leverages medical ontologies to build potential clinical contradictions over millions of medical abstracts and can help researchers systematically evaluate contradictory claims.

  • What methodologies are recommended for studying psiE in relation to environmental enteric dysfunction (EED)?

    For investigating psiE's role in environmental enteric dysfunction:

    1. Case-Control Studies: Compare psiE expression or antibody responses in subjects with and without EED

    2. Longitudinal Cohort Studies: Monitor psiE presence/abundance over time in relation to EED biomarkers

    3. Integrated Multi-omics Approach: Combine proteomics, transcriptomics, and metabolomics to understand psiE's role in EED pathogenesis

    4. Biomarker Correlation Analysis: Analyze relationships between psiE detection and established EED biomarkers

    5. Intestinal Organoid Models: To study psiE effects on epithelial barrier function in controlled systems

    Research has shown that Shigella often has a stronger relationship to linear growth faltering than other enteropathogens, with asymptomatic cases also potentially contributing to stunting . Investigators studying psiE should consider these findings when designing experiments to explore its potential contribution to EED mechanisms.

  • What bioinformatic approaches are most effective for predicting psiE epitopes for vaccine development?

    Effective bioinformatic approaches for psiE epitope prediction include:

    1. Sequence-Based Prediction: Algorithms that analyze primary sequence for potential B-cell and T-cell epitopes

    2. Structural Epitope Mapping: Based on 3D protein structure predictions

    3. Conservation Analysis: Identifying conserved regions across Shigella strains

    4. Immunogenicity Prediction: Algorithms estimating epitope binding to MHC molecules

    5. Epitope Cluster Analysis: Identifying regions with multiple overlapping epitopes

    Recent research has employed bioinformatic approaches to design multiepitope protein vaccines (MEPV) against Shigella species by identifying highly immunogenic epitopes . This methodology can be applied specifically to psiE to identify promising epitopes for vaccine development.

  • How can researchers optimize expression systems for producing functional recombinant psiE?

    Optimization of expression systems for functional psiE requires:

    1. Vector Selection: Choosing appropriate expression vectors (e.g., pET-14b has been used for Shigella vaccine constructs)

    2. Codon Optimization: Adapting codons for the expression host (e.g., E. coli optimization)

    3. Expression Host Selection: Evaluating different strains for optimal expression

    4. Induction Conditions: Optimizing temperature, inducer concentration, and duration

    5. Purification Strategy Development: Based on protein characteristics

    Optimization ParameterVariables to TestPotential Impact
    Induction temperature16°C, 25°C, 37°CFolding efficiency, solubility
    IPTG concentration0.1-1.0 mMExpression level, toxicity
    Expression duration3h, 6h, overnightYield vs. degradation
    Cell lysis methodSonication, chemical, enzymaticProtein integrity
    Purification tagsHis-tag, GST, MBPSolubility, purification efficiency

    Researchers should conduct small-scale optimization experiments before scaling up production.

  • What are the most promising approaches for incorporating psiE in Shigella vaccine development?

    Promising approaches for incorporating psiE in vaccine development include:

    1. Multiepitope Vaccine Constructs: Combining immunogenic epitopes from psiE with other Shigella antigens

    2. Adjuvant Formulation: Testing different adjuvants to enhance immune response to psiE

    3. Delivery System Development: Evaluating various delivery platforms (liposomes, nanoparticles, viral vectors)

    4. Prime-Boost Strategies: Combining different vaccine types in sequential administration

    5. Mucosal Immunity Targeting: Developing formulations that induce strong mucosal immune responses

    Research with BALB/c mice has shown promise for immunization against Shigella sonnei using multiepitope protein vaccine constructs composed of highly immunogenic epitopes from Shigella pathogenic species . These approaches could be adapted specifically for psiE-based vaccine components.

  • How can researchers assess the role of psiE in Shigella pathogenesis?

    To assess psiE's role in pathogenesis, researchers should consider:

    1. Gene Knockout Studies: Creating psiE-deficient mutants to observe virulence changes

    2. Complementation Assays: Restoring psiE function in mutants to confirm phenotype

    3. In Vivo Infection Models: Using animal models to assess virulence differences

    4. Transcriptional Analysis: Examining psiE expression patterns during infection

    5. Host Response Evaluation: Analyzing immune responses to wild-type vs. psiE-deficient strains

    Understanding psiE's contribution to pathogenesis is critical as Shigella infections are associated with significant health impacts, including linear growth faltering in children .

  • What advanced analytical techniques are recommended for studying psiE protein-protein interactions?

    Advanced techniques for studying psiE interactions include:

    1. Co-immunoprecipitation (Co-IP): For identifying protein complexes containing psiE

    2. Yeast Two-Hybrid (Y2H): For screening potential interaction partners

    3. Surface Plasmon Resonance (SPR): For quantifying binding kinetics

    4. Proximity Ligation Assay (PLA): For visualizing interactions in situ

    5. Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS): For mapping interaction interfaces

    6. Cryo-Electron Microscopy: For structural analysis of psiE complexes

    These techniques can help elucidate psiE's functional interactions with both bacterial and host proteins, providing insights into its role in Shigella pathogenesis.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.